Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-06

Clinical Trial Update: Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial of DiaPep277 in newly diagnosed Type 1 Diabetes patients has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DiaPep277 (DiaPep277)

Snippet

Sponsor: Andromeda Biotech Ltd. | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2016-06-06